Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Don't Fight The Fed: 2 Blue Chip Dividend Buys And 1 Strong Sell
05:58pm, Friday, 23'rd Sep 2022
The Fed took the most hawkish stance yet, as Powell takes a page out of Volcker's book. While the market could still go either way, there are some stocks that will do fine regardless.
The 7 Best Biotech Stocks to Buy
01:45pm, Tuesday, 20'th Sep 2022
I've written before about how biotech is the biggest technology trend of our kids' generation. Naturally, that means many people are looking for the best biotech stocks to buy.
Amgen CEO Sees Tougher Sledding for Emerging Biotechs
03:54pm, Monday, 19'th Sep 2022
Amgen Inc. ( AMGN , Financial) CEO Robert Bradway contends that small and mid-sized biotechs may find it much harder to remain independent, a situation that Fierce Pharma reported was exacerbated by n
Consumer group says drugmakers abuse U.S. patent system to keep prices high
08:41pm, Thursday, 15'th Sep 2022
Makers of the top selling drugs in the United States are costing patients billions of dollars and worsening a drug pricing crisis by abusing the U.S. patent system to stifle competition and inflate pr
Amgen Vs. Mirati: Playing To Win In KRAS Mutated Lung Cancer
01:36pm, Thursday, 15'th Sep 2022
Amgen's KRAS targeting drug Lumakras has now been approved in the US and Europe, making $77m sales in Q222. Mirati Therapeutics also has a KRAS targeting drug which may well win approval in December i
Amgen's new cancer drug faces questions about competition
01:03pm, Thursday, 15'th Sep 2022
Amgen Inc.'s AMGN, +0.17% Lumakras, which already has a type of conditional approval to treat lung cancer, produced mixed results in a closely watched clinical trial comparing the drug to docetaxel, a
Amgen CEO on New Products, M&A, Drug Pricing Legislation
03:52pm, Wednesday, 14'th Sep 2022
Amgen Inc. Chairman and Chief Executive Officer Robert Bradway discusses the biopharmaceutical company's new products, merger and acquisition strategy, and the impact of US drug pricing legislation on
3 High-Yielding Dividend Stocks That May Hike Their Payouts in the Next 2 Years
10:30am, Wednesday, 14'th Sep 2022
These are stocks all income investors should consider buying and holding.
Amgen Inc. (AMGN) Management Presents at Morgan Stanley's 2022 Global Healthcare Conference (Transcript)
02:19pm, Tuesday, 13'th Sep 2022
Amgen Inc. (NASDAQ:AMGN ) Morgan Stanley's 2022 Global Healthcare Conference Transcript September 13, 2022 9:10 AM ET Executives Bob Bradway - Chief Executive Officer Analysts Matthew Harrison - Morga
Amgen Is Looking Interesting On The Dip
07:35am, Tuesday, 13'th Sep 2022
Amgen continues to churn out respectable growth amidst a challenging economic backdrop. Its upcoming acquisition of ChemoCentryx should bolster its top-line growth.
Amgen Inc. (AMGN) European Society for Medical Oncology Annual Congress 2022 Conference Call (Transcript)
08:42pm, Monday, 12'th Sep 2022
Amgen Inc. (NASDAQ:AMGN ) European Society for Medical Oncology Annual Congress 2022 Conference Call September 12, 2022 1:30 PM ET Company Participants David Reese - Executive Vice President of Resear
Here's who could benefit from Biden's biotech initiative, according to Oppenheimer's Jared Holz
06:30pm, Monday, 12'th Sep 2022
Oppenheimer's Jared Holz on President Biden's cancer initiative and what it means for biotech in the U.S. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Courtney Garcia, Guy Adami an
AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE
04:00pm, Monday, 12'th Sep 2022
THOUSAND OAKS, Calif. , Sept. 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Bank of America Merrill Lynch's 2022 Global Healthcare Conference at 4:55 a.m.
Livent, Amgen And Some Other Big Stocks Moving Lower On Monday
03:08pm, Monday, 12'th Sep 2022 Benzinga
U.S. stocks traded higher, with the Dow Jones gaining more than 250 points on Monday. Here are some big stocks recording gains in today’s session.
DICE Therapeutics, Inc. (NASDAQ: DICE) fell 19.6%
3 Stocks Expecting Good News From the FDA
11:37am, Monday, 12'th Sep 2022 The Motley Fool
Here are the upcoming catalysts for Mirati Therapeutics, Novavax, and Heron Therapeutics.
